Go Pro
LON:APH

Alliance Pharma (APH) Share Price, News & Analysis

Alliance Pharma logo

About Alliance Pharma Stock (LON:APH)

Key Stats

Today's Range
N/A
50-Day Range
64.70
64.70
52-Week Range
N/A
Volume
N/A
Average Volume
5.95 million shs
Market Capitalization
£350.32 million
P/E Ratio
N/A
Dividend Yield
3.75%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics. It provides its products under the Aloclair, Anbesol, Asthon and Parsons, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. Alliance Pharma plc was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom.

Receive APH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alliance Pharma and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

APH Stock News Headlines

RBC Capital Reaffirms Their Hold Rating on Alliance Pharma (APH)
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
Alliance Pharma Regulatory News
See More Headlines

APH Stock Analysis - Frequently Asked Questions

Alliance Pharma's stock was trading at GBX 64.70 on January 1st, 2026. Since then, APH shares have increased by 0.0% and is now trading at GBX 64.70.

Alliance Pharma plc (LON:APH) announced its earnings results on Tuesday, April, 8th. The company reported $4.32 earnings per share for the quarter. Alliance Pharma had a negative net margin of 6.00% and a negative trailing twelve-month return on equity of 5.04%.

Shares of APH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alliance Pharma investors own include boohoo group (BOO), BP (BP), Vodafone Group Public (VOD), Aviva (AV), Babcock International Group (BAB), BAE Systems (BA) and The Gym Group (GYM).

Company Calendar

Last Earnings
4/08/2025
Today
8/02/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
LON:APH
CIK
N/A
Fax
N/A
Employees
91,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (6.20)
Trailing P/E Ratio
N/A
Forward P/E Ratio
12.47
P/E Growth
1.04
Net Income
-£33.65 million
Net Margins
-6.00%
Pretax Margin
N/A
Return on Equity
-5.04%
Return on Assets
5.98%

Debt

Debt-to-Equity Ratio
46.09
Current Ratio
2.84
Quick Ratio
1.42

Sales & Book Value

Annual Sales
£183.50 million
Price / Sales
1.91
Cash Flow
GBX 8.22 per share
Price / Cash Flow
7.87
Book Value
GBX 41.25 per share
Price / Book
1.57

Miscellaneous

Outstanding Shares
541,444,969
Free Float
N/A
Market Cap
£350.31 million
Optionable
Not Optionable
Beta
0.67
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (LON:APH) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners